About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
SITC 2022: TAP2 Deficiency Mediates Adaptive Immune Evasion and Immunotherapy Resistance in Human NSCLC
By
Kishu Ranjan
88 views
November 28, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
08:44
Johnson & Johnson
Management and Proactive Care of Adverse Events Associated with Loca…
Feat.
J. Sabari,
A. Spira
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Related Content
AUTOPLAY
ON
08:49
David Carbone
The Use of IO Doublet in PD-L1-Negative NSCLC
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
35:40
Balazs Halmos
Year in Review: Lung Cancer
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
27:04
Fengting Yan
Cancer Screening Molecular Tools
29:25
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
Feat.
Y. Chae
23:17
University of Miami Sylvester Comprehensive Cancer Center
Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…
Feat.
D. Tripathy
02:41
GRACE
Staging Disease: How Oncologists Stage NSCLC
Feat.
I. Dagogo-Jack,
M. Das,
C. Jeffrey Yang
16:10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…
Feat.
L. Raez
07:43
Yale Cancer Center
2024 Updates on NSCLC Targeted Therapies: FLAURA2 Trial - Osimertini…
Feat.
P. Janne
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
16:12
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
Feat.
R. Osarogiagbon
25:35
Total Health
NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing
Feat.
S. Kazmi
27:06
Insights from 2024 WCLC
WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion
Feat.
P. Lee
14:49
Vivek Subbiah
Year in Review: Precision Medicine
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang
19:33
ecancer
ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC
Feat.
E. Felip,
A. Spira,
A. Passaro,
A. Addeo
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage
Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …
Feat.
E. Rodriguez
45:56
Yale Cancer Center
Endocrine Adverse Events From Checkpoint Inhibitors
Feat.
K. Herold
